Table 1.
Pseudomonas aeruginosa strains and bacterial isolates (Environmental, non-CF, and CF isolates), Minimum inhibitory concentration, and 1/2 MIC of bio-AgNP used in this study.
| Reference strains or isolates | Type | Origin | bio-AgNP (µM) | |
|---|---|---|---|---|
| MIC | 1/2 MIC | |||
| PAO1 | C | Wound patient | 62.50 | 31.25 |
| PA14 | C | Burn patient | 62.50 | 31.25 |
| P1 | E | Water from the public supply system | 15.62 | 7.81 |
| P2 | E | Water from the public supply system | 31.25 | 15.62 |
| P3 | E | Water from the public supply system | 15.62 | 7.81 |
| P4 | E | Water from the public supply system | 31.25 | 15.62 |
| P5 | E | Water from the public supply system | 31.25 | 15.62 |
| P6 | non-CF | Tracheal secretion | 31.25 | 15.62 |
| P7 | non-CF | Pleural fluid | 31.25 | 15.62 |
| P8 | non-CF | Knee wound | 31.25 | 15.62 |
| P9 | non-CF | Tracheal secretion | 31.25 | 15.62 |
| P10 | non-CF | Sacral area | 31.25 | 15.62 |
| P11 | CF | Sputum and oropharyngeal | 15.62 | 7.81 |
| P12 | CF | Sputum and oropharyngeal | 15.62 | 7.81 |
| P13 | CF | Sputum and oropharyngeal | 15.62 | 7.81 |
| P14 | CF | Sputum and oropharyngeal | 15.62 | 7.81 |
| P15 | CF | Sputum and oropharyngeal | 15.62 | 7.81 |
C, clinical isolates.
E, environmental isolates.
Non-CF, clinical isolates obtained from non-cystic fibrosis patients.
CF, clinical isolates obtained from cystic fibrosis patients.
MIC, Minimum inhibitory concentration.